Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2354-2361

  Ludvik, Bernhard ^a   Nolan, John J ^a   Roberts, Anne ^a   Baloga, Joseph ^a   Joyce, Mary ^a   Bell, Jo M ^a   Olefsky, Jerrold M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hepatic vein catheter technique; Non insulin dependent diabetes mellitus; OG CLAMP; Postprandial hyperglycemia; Splanchnic glucose uptake

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HEPATIC VEIN; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; VEIN CATHETERIZATION;

EID: 0030671249     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119775     Document Type: Article

References (24)

1. DeFronzo, R.A. 1988. Lilly lecture 1987. The triumvirate: beta-cell, muscle, and liver. A collusion responsible for NIDDM. Diabetes. 37:667-687.
2. Felig, P., J. Wahren, and R. Hendler. 1975. Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes. 24:468-475.
3. Felig, P., J. Wahren, and R. Hendler. 1978. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes. 27:121-126.
4. Ferrannini, E., J. Wahren, P. Felig, and R.A. DeFronzo. 1980. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism. 29:28-35.
5. Butler, P.C., and R.A. Rizza. 1991. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes. 40:73-81.
6. Firth, R., P. Marsh, I. Hansen, and R. Rizza. 1986. Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus: roles of hepatic and extrahepatic tissues. J. Clin. Invest. 77:1525-1532.
7. Mitrakou, A., D. Kelley, T. Veneman, T. Jenssen, T. Pangburn, J. Reilly, and J. Gerich. 1990. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes. 39:1381-1391.
8. Ludvik, B., J.J. Nolan, A. Roberts, J. Baloga, M. Joyce, J.M. Bell, and J.M. Olefsky. 1995. A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J. Clin. Invest. 95:2232-2238.
9. Olefsky, J. 1981. Insulin resistance and insulin action: an in vitro and in vivo perspective. Diabetes. 30:148-162.
10. Olefsky, J.M., and O.G. Kolterman. 1981. Mechanisms of insulin resistance in obesity and non-insulin-dependent (type II) diabetes. Am. J. Med. 70: 151-168.
11. Molina, J.M., A.D. Baron, S.V. Edelman, G. Brechtel, P. Wallace, and J. Olefsky. 1990. Use of a variable tracer infusion method to determine glucose turnover in man. Am. J. Physiol. 258:E16-E23.
12. Rowell, L.B., J.R. Blackmon, and R.A. Bruce. 1964. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J. Clin. Invest. 43:1677-1690.
13. DeFronzo, R.A., E. Ferrannini, R. Hendler, P. Felig, and J. Wahren. 1983. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 32:35-45.
14. Ferrannini, E., D.C. Simonson, L.D. Katz, G. Reichard, S. Bevilacqua, E.J. Barrett, M. Olsson, and R.A. DeFronzo. 1988. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism. 37:79-85.
15. Prager, R., P. Wallace, and J.M. Olefsky. 1986. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J. Clin. Invest. 78:472-481.
16. Bergmann, R.N., D.T. Finegood, and M. Ader. 1985. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6:45-86.
17. Desbuquois, B., and G.D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33:732-738.
18. Faber, O.K., C. Binder, J. Markussen, L.G. Heding, V.K. Naithani, H. Kuzuya, B.P. Blix, D.L. Horwitz, and A.M. Rubenstein. 1978. Characterization of seven C-peptide antisera. Diabetes. 27:170-177.
19. Unger, R., A. Eisenhart, M. McCall, and L. Madison. 1961. Glucagon antibodies and an immunoassay for glucagon. J. Clin. Invest. 48:1280-1289.
20. Gasic, S., C.H. Kleinbloesem, G. Heinz, and W. Waldhäusl. 1991. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans. J. Cardiovasc. Pharmacol. 17:615-620.
21. Cummins, A.J. 1952. Absorption of glucose and methionine from the human intestine. Influence of the glucose concentration in the blood and the intestinal lumen. J. Clin. Invest. 31:928-937.
22. Radziuk, J., T.J. McDonald, D. Rubenstein, and J. Dupre. 1978. Initial splanchnic extraction of ingested glucose in normal man. Metabolism. 27:657-669.
23. Consoli, A. 1992. Role of liver in pathophysiology of NIDDM. Diabetes Care. 15:430-441.
24. Magnusson, I., D.L. Rothman, L. Katz, R.G. Shulman, and G.I. Shulman. 1992. Increased rate of gluconeogenesis in type II diabetes mellitus. J. Clin. Invest. 90:1323-1327.